Prognostic and Clinical Implications of WNK Lysine Deficient Protein Kinase 1 Expression in Patients With Hepatocellular Carcinoma

MLA

Kun Tu Yeh, et al. Prognostic and Clinical Implications of WNK Lysine Deficient Protein Kinase 1 Expression in Patients With Hepatocellular Carcinoma. Sept. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7e794aec2c71dc4b99f48d8da5467370&authtype=sso&custid=ns315887.

APA

Kun Tu Yeh, Yi Jung Ho, Jeng-Wei Lu, Yueh Min Lin, Jungshan Chang, & Zhiyuan Gong. (2020). Prognostic and Clinical Implications of WNK Lysine Deficient Protein Kinase 1 Expression in Patients With Hepatocellular Carcinoma.

Chicago

Kun Tu Yeh, Yi Jung Ho, Jeng-Wei Lu, Yueh Min Lin, Jungshan Chang, and Zhiyuan Gong. 2020. “Prognostic and Clinical Implications of WNK Lysine Deficient Protein Kinase 1 Expression in Patients With Hepatocellular Carcinoma,” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7e794aec2c71dc4b99f48d8da5467370&authtype=sso&custid=ns315887.